# Lite Strategy, Inc.: overview LITS · Nasdaq · CIK 1262104 · [Financials](/sectors/financials.md) · fiscal year ends Jun 30 Pages: [Overview](/companies/lits.md) · [Financials](/companies/lits/financials.md) · [Filings](/companies/lits/filings.md) · [Insiders](/companies/lits/insiders.md) Latest reported revenue: [$0](/filings/0001193125-25-220421.md) for Q4 FY2025, three months to 2025-06-30, from the 10-K filed Sep 26, 2025 (XBRL us-gaap:Revenues, accession 0001193125-25-220421). ## Last eight quarters | Line item | Unit | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [0.0](/filings/0000950170-24-125328.md) | [0.0](/filings/0000950170-25-018809.md) | [0.0](/filings/0000950170-25-070276.md) | [0.0 d](/filings/0001193125-25-220421.md) | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [(1.20)](/filings/0001193125-25-283111.md) | [(0.40)](/filings/0001193125-26-053215.md) | [(0.39)](/filings/0001193125-26-220687.md) | not reported | [(0.12)](/filings/0001193125-25-283111.md) | [(0.82)](/filings/0001193125-26-053215.md) | [(0.66)](/filings/0001193125-26-220687.md) | not reported | | Free cash flow | $k | not reported | not reported | [(3,267) d](/filings/0001193125-26-220687.md) | [(2,461) d](/filings/0001193125-26-405328.md) | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure. ## Last five fiscal years | Line item | Unit | FY2022 (2022-06-30) | FY2023 (2023-06-30) | FY2024 (2024-06-30) | FY2025 (2025-06-30) | FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [40.7](/filings/0000950170-23-049927.md) | [48.8](/filings/0000950170-24-108185.md) | [65.3](/filings/0001193125-25-220421.md) | [0.0](/filings/0001193125-25-220421.md) | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(185.5%)](/filings/0000950170-23-049927.md) | [(75.3%)](/filings/0000950170-24-108185.md) | [22.3%](/filings/0001193125-25-220421.md) | not reported | not reported | | Net margin | % | [(132.7%)](/filings/0000950170-23-055978.md) | [(65.6%)](/filings/0001193125-25-220421.md) | [27.6%](/filings/0001193125-26-405328.md) | not reported | not reported | | Diluted EPS | $ per share | [(9.99)](/filings/0000950170-23-049927.md) | [(4.78)](/filings/0000950170-24-108185.md) | [2.67](/filings/0001193125-25-220421.md) | [(2.39)](/filings/0001193125-26-405328.md) | [(2.06)](/filings/0001193125-26-405328.md) | | Free cash flow | $m | [(49.2)](/filings/0000950170-23-049927.md) | [(52.5)](/filings/0000950170-24-108185.md) | [(50.5)](/filings/0001193125-25-220421.md) | [(20.8)](/filings/0001193125-26-405328.md) | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/lits/insiders.md) | Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing | | --- | --- | --- | --- | ---: | ---: | ---: | --- | | 2025-07-23 | [Glover Nicholas](/insiders/1578888.md) | Director | Purchase (P) | 1,000 | $6.00 | $6.0k | [Form 4](/filings/0001193125-26-432220.md) | | 2025-07-22 | [Glover Nicholas](/insiders/1578888.md) | Director | Purchase (P) | 1,000 | $6.55 | $6.5k | [Form 4](/filings/0001193125-26-432220.md) | ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $1.2m | 1,247,350 | | Reduced −497,350 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $942.2k | 1,021,892 | | Reduced −21,421 | | [RLH Capital LLC](/funds/2008031.md) | 2026-06-30 | $743.9k | 806,433 | | New +806,433 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $562.4k | 609,700 | Call | Added +572,300 | | [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $513.8k | 557,011 | | Reduced −57,431 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $337.1k | 365,019 | | Reduced −36,072 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $329.8k | 357,529 | | Reduced −372,570 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $254.4k | 275,829 | | Added +117,938 | | [MARSHALL WACE, LLP](/funds/1318757.md) | 2026-06-30 | $214.3k | 232,979 | | Reduced −100,529 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $180.2k | 195,392 | | Added +1,397 | ## Recent filings [All 900 filings](/companies/lits/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-28 | 16:10 ET | [10-K](/filings/0001193125-26-405328.md) | Annual report, period 2026-06-30 | 0001193125-26-405328 | | 2026-07-30 | 08:30 ET | [8-K](/filings/0001193125-26-325026.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-325026 | | 2026-07-24 | 17:29 ET | [8-K](/filings/0001193125-26-316284.md) | 7.01 Regulation FD disclosure | 0001193125-26-316284 | | 2026-05-13 | 08:35 ET | [8-K](/filings/0001193125-26-220697.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-220697 | | 2026-05-13 | 08:30 ET | [10-Q](/filings/0001193125-26-220687.md) | Quarterly report, period 2026-03-31 | 0001193125-26-220687 | | 2026-02-17 | 08:50 ET | [8-K](/filings/0001193125-26-053243.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-053243 | | 2026-02-17 | 08:45 ET | [10-Q](/filings/0001193125-26-053215.md) | Quarterly report, period 2025-12-31 | 0001193125-26-053215 | | 2026-02-12 | 17:10 ET | [8-K](/filings/0001193125-26-049005.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-049005 | | 2025-12-30 | 16:00 ET | [DEF 14A](/filings/0001193125-25-337041.md) | Proxy statement, period 2025-12-30 | 0001193125-25-337041 | | 2025-12-30 | 06:00 ET | [8-K](/filings/0001193125-25-335761.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-335761 | ## Latest annual report [Form 10-K for the fiscal year ended Jun 30, 2026](/filings/0001193125-26-405328.md), filed Sep 28, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1262104 - Tickers: LITS - Exchange: Nasdaq - SIC code: 6199 Finance Services - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 26, 2026, 17:45 ET. No prices; not investment advice.